Why Cargo Therapeutics Stock Rocketed Nearly 20% Higher This Week

Along with quarterly results, the clinical-stage company provided an encouraging business update. This was a good week to be invested in clinical-stage biotech Cargo Therapeutics (CRGX 1.04%). The company dropped its second-quarter earnings release, and investors were quite cheered by the progress the business is making. They also liked that its net loss for the period wasn't as deep as analysts expected. Across the five trading days, Cargo's stock price rose by just under 19%, according to data compiled by ...